Search
for
Sort by
Research 691–720 of 1000+
- The effect of gonadoliberin analog treatment in precocious puberty on polycystic ovarian syndrome prevalence in adulthood
- Corticotropin releasing factor-1 receptor antagonism associated with favorable outcomes of male reproductive health biochemical parameters
- Management of “hyperandrogenism” confounded by dermatology biotin prescriptions
- Treatment of hirsutism and acne in hyperandrogenism
- Vitamin D status in polycystic ovary syndrome
- Finasteride
- Testosterone in Women: Measurement and Therapeutic Use
- Thyroid hormone action on skin.
- PMON281 PERSISTENT VIRILIZATION AND VASOMOTOR SYMPTOMS IN A TRANSMAN 5-YEARS POST TESTOSTERONE WITHDRAWAL
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Menopause - Andropause - Anti-Aging 2008, 11.-13. Dezember 2008, Wien - Abstracts
- Diagnostik und Therapie der kutanen Androgenisierung im klimakterischen Übergang sowie in der Peri- und Postmenopause: Hirsutismus und Alopezie
- Adverse Side Effects of 5α‐Reductase Inhibitors Therapy: Persistent Diminished Libido and Erectile Dysfunction and Depression in a Subset of Patients
- INSULIN-LOWERING MEDICATIONS IN POLYCYSTIC OVARY SYNDROME
- Testosterone Improves Antidepressant‐Emergent Loss of Libido in Women: Findings from a Randomized, Double‐Blind, Placebo‐Controlled Trial
- Novel Systematics of Nomenclature and Classification of Female Functional Androgenization (Including Polycystic Ovary Syndrome and Non-Classic Congenital Adrenal Hyperplasia)
- Kutane Androgenisierung - Effluvium, Hirsutismus, Akne
- A Randomized Trial of Oral DHEA Treatment for Sexual Function, Well-Being, and Menopausal Symptoms in Postmenopausal Women with Low Libido
- National scientific medical meeting 1996 abstracts
- Polycystic Ovary Syndrome
- Metabolic syndrome in Greek women with polycystic ovary syndrome: prevalence, characteristics and associations with body mass index. A prospective controlled study
- Polycystic Ovarian Syndrome: The Androgenized Adolescent
- Markers of peripheral androgen action in vivo and in vitro
- Prematüre Pubarş Olgularının Değerlendirilmesi: Tek Merkez Deneyimi
- Non polycystic ovary syndrome–related endocrine disorders associated with hirsutism
- Quantitative Models for the Study of Hair Growth <i>in Vivo</i><sup>a</sup>
- Revisiting hyper- and hypo-androgenism by tandem mass spectrometry
- Antiandrogen Treatment with Spironolactone and Linestrenol Decreases Bone Mineral Density in Eumenorrhoeic Women with Androgen Excess
- 5α-Reductase Inhibitors, Chemical and Clinical Models
- Obesity, polycystic ovarian syndrome and thyroid dysfunction in women with epilepsy